We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Hyperlipoproteinemia is the most important public health risk factor for ischemic heart disease and is still responsible for a high proportion of the annual deaths in Austria. Clofibrate and other structurally related compounds are hypolipidemic drugs used in the treatment of hyperlipoproteinemia. Peroxisome proliferators enhance peroxisomal enzyme(More)
  • 1